These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8985527)

  • 1. Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience.
    Bhutta ZA
    Ann Trop Paediatr; 1996 Dec; 16(4):299-306. PubMed ID: 8985527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third generation cephalosporins in multi-drug resistant typhoid fever.
    Gulati S; Marwaha RK; Singhi S; Ayyagari A; Kumar L
    Indian Pediatr; 1992 Apr; 29(4):513-6. PubMed ID: 1506109
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic re-appraisal of multiple drug resistant Salmonella typhi (MDRST) in Pakistani children.
    Hazir T; Qazi SA; Abbas KA; Khan MA
    J Pak Med Assoc; 2002 Mar; 52(3):123-7. PubMed ID: 12071068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment.
    Rathore MH; Bux D; Hasan M
    South Med J; 1996 Feb; 89(2):235-7. PubMed ID: 8578359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
    Dutta P; Mitra U; Dutta S; De A; Chatterjee MK; Bhattacharya SK
    Indian J Med Res; 2001 Jun; 113():210-3. PubMed ID: 11816954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan.
    Bhutta ZA; Khan IA; Shadmani M
    Antimicrob Agents Chemother; 2000 Feb; 44(2):450-2. PubMed ID: 10639383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
    Girgis NI; Sultan Y; Hammad O; Farid Z
    Pediatr Infect Dis J; 1995 Jul; 14(7):603-5. PubMed ID: 7567290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of multidrug resistant typhoid in 58 children.
    Naqvi SH; Bhutta ZA; Farooqui BJ
    Scand J Infect Dis; 1992; 24(2):175-9. PubMed ID: 1641594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol.
    Tatli MM; Aktas G; Kosecik M; Yilmaz A
    Int J Antimicrob Agents; 2003 Apr; 21(4):350-3. PubMed ID: 12672582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric fever in Karachi: current antibiotic susceptibility of Salmonellae isolates.
    Abdullah FE; Haider F; Fatima K; Irfan S; Iqbal MS
    J Coll Physicians Surg Pak; 2012 Mar; 22(3):147-50. PubMed ID: 22414353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.
    Islam A; Butler T; Kabir I; Alam NH
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1572-5. PubMed ID: 8215265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical profile, antibiotic susceptibility pattern of bacterial isolates and factors associated with complications in culture-proven typhoid patients admitted to an urban hospital in Bangladesh.
    Khatun H; Islam SB; Naila NN; Islam SA; Nahar B; Alam NH; Ahmed T
    Trop Med Int Health; 2018 Apr; 23(4):359-366. PubMed ID: 29432657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Typhoid fever: facing the challenge of resistant strains].
    Weill FX
    Med Sci (Paris); 2010 Nov; 26(11):969-75. PubMed ID: 21106179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of clinical profile and antibiotic response in typhoid fever.
    Chowta MN; Chowta NK
    Indian J Med Microbiol; 2005 Apr; 23(2):125-7. PubMed ID: 15928444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome.
    Bhutta ZA; Mansoorali N; Hussain R
    J Infect; 1997 Nov; 35(3):253-6. PubMed ID: 9459398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-resistant typhoid fever.
    Kabra SK; Madhulika ; Talati A; Soni N; Patel S; Modi RR
    Trop Doct; 2000 Oct; 30(4):195-7. PubMed ID: 11075647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone versus chloramphenicol in the treatment of enteric fever.
    Girgis NI; Kilpatrick ME; Farid Z; Mikhail IA; Bishay E
    Drugs Exp Clin Res; 1990; 16(12):607-9. PubMed ID: 2130002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins.
    Soe GB; Overturf GD
    Rev Infect Dis; 1987; 9(4):719-36. PubMed ID: 3125577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-drug resistant typhoid fever in hospitalised children. Clinical, bacteriological and epidemiological profiles.
    Rasaily R; Dutta P; Saha MR; Mitra U; Lahiri M; Pal SC
    Eur J Epidemiol; 1994 Feb; 10(1):41-6. PubMed ID: 7957789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of typhoid fever: randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol.
    Acharya G; Butler T; Ho M; Sharma PR; Tiwari M; Adhikari RK; Khagda JB; Pokhrel B; Pathak UN
    Am J Trop Med Hyg; 1995 Feb; 52(2):162-5. PubMed ID: 7872445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.